IUBio

Butyrolactone in Depression /La Butyrolactone dans la depression

L'Ombre du Z Champignac zorglub at bulgroZZ.org
Mon May 17 18:50:16 EST 1999


La butyrolactone est un precurseur du Gamma-OH qui est
transforme,endogenement,en Gamma-OH.

Produit sous le nom de Renewtrient chez les Anglo-Saxons. Le Gamma-OH
a de nombreuses proprietes utiles contre la depression,l'anxiete et
l'alcoolisme notamment.

Here is a small report on the use of Gamma-OH (ghb) precursor
Butyrolactone in depression.

Gamma-OH is also called GHB and Xyrem in the USA.

Xyrem will probably be approved by your FDA.

Butyrolactone is sold all over the US with the tradename of
Renewtrient.

La butyrolactone est un precurseur du Gamma-OH...

                               RENEWTRIENT (Butyrolactone)

    The natural alternative in physical and mental
                                      health

     

    Butyrolactone to Alleviate the
    Symptoms of Depression

    Dr. Kenneth Cochrane

    RenewTrient Products:

    Abstract: Eighteen volunteers who met DSM-IV criteria for Major
    Depressive Disorder were measured for degree and severity of
depression
    (subjective and objective). Measurement was conducted both before
and
    after the initial administration of RenewTrient and at monthly
    intervals for a four month period. Volunteers were maintained at a
    standard dosage of RenewTrient during this period. Concurrently, a
    healthy group of ten volunteers were studied under the same
conditions
    and administered the same measurements. Healthy volunteers did not
meet
    criteria for Major Depressive Disorder or any other Psychiatric
    Disorder. Results of the study indicate profound positive changes
(78%)
    in symptomatology and measured pathology upon initial
administration of
    RenewTrient and over the course of the study. Participants
reported
    improved mood (78%); improvement in sleep patterns (70%);
improvement
    in quality of sleep (76%); improvement in sexual feelings (44%);
    decrease in anxiety (88%) and increased feelings of well-being
(82%).
    Several additional and unexpected effects observed by the
researcher
    during the study were noted. These effects were not controlled for
and
    are therefore anecdotal: (1) subjects who were previously unable
to
    discuss pertinent issues (grief, loss, early trauma) were able to
    readily discuss and work with these issues while being maintained
on
    RenewTrient; (2) subjects were more able to work with
visualization,
    meditation and relaxation techniques during the time they were
taking
    RenewTrient; (3) trance induction (for hypnotherapy) was more
easily
    accomplished in subjects who were originally resistant to this
mode of
    treatment. Healthy volunteers differed greatly from the depressed
    volunteers in both the subjective effect of RenewTrient and the
    experienced changes in affect and mood. Most healthy controls
reported
    somnolence (92%) as the major subjective effect of RenewTrient.
These
    results strongly suggest that the active components of
RenewTrient,
    although beneficial to the general population, are particularly
    beneficial to individuals suffering from the symptoms of
depression.
    Because of the small sample size and the short duration of the
study,
    suggestions for further research are offered.

     

     To request a copy of the above research enter your name
                         and e-mail/mailing address.

          Send mail to headdoc at erols.com with questions or comments
about this web site.
                                   Last modified: 4/99


Note:The anti-depressant effects of GHB have been discovered by Claude
Rifat,in Switzerland.



More information about the Neur-sci mailing list

Send comments to us at biosci-help [At] net.bio.net